PAPER Chu LW, Chiu KC, Hui SL, Yu GK, Tsui WJ, Lee PW

The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong.

Ann Acad Med Singapore. 2000 Jul;29(4):474-85. PubMed.

PAPER Korczyn AD

Muscarinic M(1) agonists in the treatment of Alzheimer's disease.

Expert Opin Investig Drugs. 2000 Oct;9(10):2259-67. PubMed.

PAPER Sramek JJ, Frackiewicz EJ, Cutler NR

Review of the acetylcholinesterase inhibitor galanthamine.

Expert Opin Investig Drugs. 2000 Oct;9(10):2393-402. PubMed.

PAPER Kumar-Singh S, De Jonghe C, Cruts M, Kleinert R, Wang R, Mercken M, De Strooper B, Vanderstichele H, Löfgren A, Vanderhoeven I, Backhovens H, Vanmechelen E, Kroisel PM, Van Broeckhoven C

Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease.

Hum Mol Genet. 2000 Nov 1;9(18):2589-98. PubMed.

PAPER Praticò D, Delanty N

Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease.

Am J Med. 2000 Nov;109(7):577-85. PubMed.

PAPER Lambert JC, Mann D, Goumidi L, Harris J, Pasquier F, Frigard B, Cottel D, Lendon C, Iwatsubo T, Amouyel P, Chartier-Harlin MC

A FE65 polymorphism associated with risk of developing sporadic late-onset alzheimer's disease but not with Abeta loading in brains.

Neurosci Lett. 2000 Oct 20;293(1):29-32. PubMed.

PAPER Rebeck GW

Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease.

Neurosci Lett. 2000 Oct 20;293(1):75-7. PubMed.

PAPER Ulery PG, Strickland DK

LRP in Alzheimer's disease: friend or foe?

J Clin Invest. 2000 Nov;106(9):1077-9. PubMed.

PAPER Kang DE, Pietrzik CU, Baum L, Chevallier N, Merriam DE, Kounnas MZ, Wagner SL, Troncoso JC, Kawas CH, Katzman R, Koo EH

Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.

J Clin Invest. 2000 Nov;106(9):1159-66. PubMed.

PAPER Liang JJ

Interaction between beta-amyloid and lens alphaB-crystallin.

FEBS Lett. 2000 Nov 3;484(2):98-101. PubMed.

PAPER Huber G, März W, Martin JR, Malherbe P, Richards JG, Sueoka N, Ohm T, Hoffmann MM

Characterization of transgenic mice expressing apolipoprotein E4(C112R) and apolipoprotein E4(L28P; C112R).

Neuroscience. 2000;101(1):211-8. PubMed.

PAPER Gibson GE, Zhang H, Sheu KR, Park LC

Differential alterations in antioxidant capacity in cells from Alzheimer patients.

Biochim Biophys Acta. 2000 Nov 15;1502(3):319-29. PubMed.

PAPER Oshiro S, Kawahara M, Kuroda Y, Zhang C, Cai Y, Kitajima S, Shirao M

Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells.

Biochim Biophys Acta. 2000 Nov 15;1502(3):405-14. PubMed.

PAPER Huang C, Wahlund L, Dierks T, Julin P, Winblad B, Jelic V

Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study.

Clin Neurophysiol. 2000 Nov;111(11):1961-7. PubMed.

PAPER Meda C, Vegeto E, Pollio G, Ciana P, Patrone C, Pellicciari C, Maggi A

Oestrogen prevention of neural cell death correlates with decreased expression of mRNA for the pro-apoptotic protein nip-2.

J Neuroendocrinol. 2000 Nov;12(11):1051-9. PubMed.